DRNA
T. Rowe Price Associates’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,682,596
| Closed | -$54.1M | – | 3076 |
|
|
2021
Q3 | $54.1M | Buy |
2,682,596
+699,671
| +35% | +$14.1M | 0.01% | 976 |
|
|
2021
Q2 | $74M | Buy |
1,982,925
+289,743
| +17% | +$10.8M | 0.01% | 891 |
|
|
2021
Q1 | $43.3M | Sell |
1,693,182
-379,035
| -18% | -$9.69M | ﹤0.01% | 1050 |
|
|
2020
Q4 | $45.7M | Sell |
2,072,217
-21,461
| -1% | -$473K | ﹤0.01% | 989 |
|
|
2020
Q3 | $37.7M | Sell |
2,093,678
-300,804
| -13% | -$5.41M | ﹤0.01% | 968 |
|
|
2020
Q2 | $60.8M | Sell |
2,394,482
-232,744
| -9% | -$5.91M | 0.01% | 784 |
|
|
2020
Q1 | $48.3M | Sell |
2,627,226
-653,798
| -20% | -$12M | 0.01% | 799 |
|
|
2019
Q4 | $72.3M | Buy |
3,281,024
+2,004,112
| +157% | +$44.2M | 0.01% | 777 |
|
|
2019
Q3 | $18.3M | Buy |
1,276,912
+123,913
| +11% | +$1.78M | ﹤0.01% | 1179 |
|
|
2019
Q2 | $18.2M | Buy |
1,152,999
+406,960
| +55% | +$6.41M | ﹤0.01% | 1199 |
|
|
2019
Q1 | $10.9M | Buy |
746,039
+413,424
| +124% | +$6.06M | ﹤0.01% | 1307 |
|
|
2018
Q4 | $3.56M | Buy |
+332,615
| New | +$3.56M | ﹤0.01% | 1443 |
|
|
2018
Q2 | – | Sell |
-83,594
| Closed | -$799K | – | 2597 |
|
|
2018
Q1 | $799K | Buy |
+83,594
| New | +$799K | ﹤0.01% | 1876 |
|
|
2014
Q2 | – | Sell |
-172,800
| Closed | -$4.88M | – | 2555 |
|
|
2014
Q1 | $4.88M | Buy |
+172,800
| New | +$4.88M | ﹤0.01% | 1436 |
|